A year-old Canadian woman originally from the Democratic Republic of Congo returned to Canada after a month stay in the Congo where she was visiting friends and relatives. She had taken no chemoprophylaxis for malaria and sought no pretravel advice. Three days after returning to Canada, she began to have fever, nausea and vomiting. She visited a walk-in clinic, but she was sent home with no specific therapy. Later that day, she presented to an emergency department, and she was again discharged home. Four days after the onset of symptoms, she was taken to the emergency department by her family, who found her to be lethargic, confused, feverish and incontinent. Thick and thin smears for malaria were performed.
Seydel, Karl B. Chaccour, Carlos J et al. Section Navigation. We stress, however, that the global burden of malaria is still dominated by the AFRO countries which are least able to raise financial resources to tackle their high rates of malaria death and disability. Footnotes Competing interests: None declared.
Clinical trials do not demonstrate efficacy for other ancillary treatments, including anticytokine agents, chelation agents, corticosteroids, mannitol, dextran, heparin, and malaria hyperimmunoglobulin [ 18, 19 ]. Durnez L, Coosemans M: Residual transmission of malaria: an old issue for new approaches. Most reported malaria cases in EU were travel related. Human efforts to control malaria have markedly restricted its distribution during the 20th century. We refer the interested reader to a recent Givewell conversation note with an expert on insecticide resistance for more detailed information on this topic . Tropical medicine: years of progress. Lancet Infect Dis. Annual Plasmodium falciparum entomological inoculation rates EIR across Africa: literature survey, internet access and review.